##gff-version 3
##sequence-region Q96QE3 1 1844
Q96QE3	UniProtKB	Chain	1	1844	.	.	.	ID=PRO_0000317618;Note=ATPase family AAA domain-containing protein 5	
Q96QE3	UniProtKB	Nucleotide binding	1132	1139	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q96QE3	UniProtKB	Motif	1428	1432	.	.	.	Note=LXCXE motif	
Q96QE3	UniProtKB	Compositional bias	1589	1599	.	.	.	Note=Poly-Ser	
Q96QE3	UniProtKB	Modified residue	44	44	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q96QE3	UniProtKB	Modified residue	219	219	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q96QE3	UniProtKB	Modified residue	306	306	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:23186163	
Q96QE3	UniProtKB	Modified residue	311	311	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q96QE3	UniProtKB	Modified residue	354	354	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q4QY64	
Q96QE3	UniProtKB	Modified residue	369	369	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q96QE3	UniProtKB	Modified residue	602	602	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q96QE3	UniProtKB	Modified residue	614	614	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:21406692;Dbxref=PMID:19690332,PMID:21406692	
Q96QE3	UniProtKB	Modified residue	621	621	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:17525332;Dbxref=PMID:17525332	
Q96QE3	UniProtKB	Modified residue	817	817	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q96QE3	UniProtKB	Modified residue	1116	1116	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q96QE3	UniProtKB	Cross-link	127	127	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q96QE3	UniProtKB	Alternative sequence	1205	1844	.	.	.	ID=VSP_031097;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96QE3	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_038572;Note=T->S;Dbxref=dbSNP:rs9910051	
Q96QE3	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_038573;Note=P->S;Dbxref=dbSNP:rs3816780	
Q96QE3	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_038574;Note=E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs11080134,PMID:15489334	
Q96QE3	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_079496;Note=D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26282398;Dbxref=dbSNP:rs367699401,PMID:26282398	
Q96QE3	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_038575;Note=R->K;Dbxref=dbSNP:rs17826219	
Q96QE3	UniProtKB	Natural variant	699	699	.	.	.	ID=VAR_038576;Note=N->H;Dbxref=dbSNP:rs3764421	
Q96QE3	UniProtKB	Natural variant	1419	1419	.	.	.	ID=VAR_038577;Note=Y->H;Dbxref=dbSNP:rs11657270	
Q96QE3	UniProtKB	Mutagenesis	1169	1169	.	.	.	Note=No effect on the RAD9A interaction after MMS exposure. Resists to DNA damage after MMS exposure. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983387;Dbxref=PMID:15983387	
Q96QE3	UniProtKB	Mutagenesis	1187	1187	.	.	.	Note=Weakly affects the RAD9A interaction after MMS exposure. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983387;Dbxref=PMID:15983387	
Q96QE3	UniProtKB	Mutagenesis	1430	1430	.	.	.	Note=Abolishes RB1 binding. Abolishes RB1 binding%3B when associated with K-1432. Weakly detected after methyl methane-sulfonate (MMS) treatment. Expression detected after MMS treatment%3B when associated with K-1432. Weakly affects the RAD9A interaction after MMS exposure. No effect on the RAD9A interaction after MMS exposure%3B when associated with K-1432. Resists to DNA damage after MMS exposure%3B when associated with K-1432. C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983387;Dbxref=PMID:15983387	
Q96QE3	UniProtKB	Mutagenesis	1432	1432	.	.	.	Note=Abolishes RB1 binding%3B when associated with G-1430. Expression detected after methyl methane-sulfonate (MMS) treatment%3B when associated with G-1430. No effect on the RAD9A interaction after MMS exposure%3B when associated with G-1430. Resists to DNA damage after MMS exposure%3B when associated with G-1430. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15983387;Dbxref=PMID:15983387	
Q96QE3	UniProtKB	Sequence conflict	95	95	.	.	.	Note=N->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96QE3	UniProtKB	Sequence conflict	465	465	.	.	.	Note=T->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96QE3	UniProtKB	Sequence conflict	475	475	.	.	.	Note=N->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96QE3	UniProtKB	Sequence conflict	612	612	.	.	.	Note=I->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96QE3	UniProtKB	Sequence conflict	1203	1203	.	.	.	Note=K->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
